Avalor Therapeutics is a Health Care startup that recently received a $335.00KPre Seed Round investment on 05 December 2023. As an investor, this presents an intriguing opportunity to support a promising company in the health care industry. Avalor Therapeutics' focus on leveraging innovative technologies and approaches to improve healthcare outcomes makes them a compelling prospect for investment.
Avalor Therapeutics
Breakthrough precision medicines for chronic inflammation
Kenmore, United States
3 employees
Pre-Seed
Total: $335.00K
Health Care, Health and Wellness
General Information
Company Name
Avalor Therapeutics
Location
Kenmore, United States
Kenmore, United States
Employees
3
Industries
Health Care, Health and Wellness
Funding Stage
Pre-Seed
Social
BounceWatch is an independent company data service, not affiliated with Avalor Therapeutics. To contact Avalor Therapeutics, visit avalortx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Avalor Therapeutics compare?
A PDF of Avalor Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Avalor Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Avalor Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Health Care
About Avalor Therapeutics
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $335.00K | - |
|
05 Dec 2023 |
Avalor Therapeutics Alternatives & Competitors
View All Alternatives
Avalor Therapeutics vs
Agomab
Belgium
Unlocking Disease Modification in Fibro-Inflammation
Series D
78 employees
Biotechnology, Health Care
Avalor Therapeutics vs
Redefining Immunology and Inflammation with Precision
Series B
95 employees
Biotechnology, Health Care
Avalor Therapeutics vs
ACEA Therapeutics, Inc
United States
Committed to improving the lives of patients with chronic and life-threatening diseases.
5 employees
Biotechnology, Health Care
FAQ About Avalor Therapeutics
Breakthrough precision medicines for chronic inflammation
Avalor Therapeutics is headquartered in Kenmore, United States.
Avalor Therapeutics operates in Health Care and Health and Wellness.
Avalor Therapeutics has approximately 3 employees.
Avalor Therapeutics has completed 1 funding round, raising a total of $335.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Avalor Therapeutics include Agomab, Mirador Therapeutics, ACEA Therapeutics, Inc, Kineta (Reverse Merger With Yumanity Therapeutics), Excision BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avalor Therapeutics and Agomab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Avalor Therapeutics, https://bouncewatch.com/company/avalor-therapeutics, updated 12 September 2024. When citing, please name BounceWatch and link this page.
